Patients For Affordable Drugs Continues Fight Against Big Pharma's Attempts To Undermine Medicare Drug Price Negotiation In Landmark Case: AstraZeneca Pharmaceuticals LP et al. v. Becerra et al.

My name is Melissa Tavares, I am 31 years old and from Edgewater, Maryland. I am a mother of two, with both my son Victor and daughter Nina diagnosed with epilepsy. Parenthood has thus remained a blessing but it has come with its tremendous challenges as no one ever expects to have two toddlers with medical conditions that require expensive medications.

We are deeply concerned that opposition to the use of QALYs could lead to broader proscriptions that could block any kind of value analysis, which would be a huge disservice to patients like me and millions of others who pay unjustified drug prices.

Moderna, BioNTech And Pfizer Took Interest Only After The Key Discovery Funded By U.S. Taxpayers Through NIH

Patients And All Americans Should Be Getting A Better Deal On Vaccines They Paid To Make Possible

I am Linda Richardson, from Port Charlotte, Florida, and I have had Multiple Sclerosis (MS) for the past 23 years, going on 24.

Update To The Hidden Hand: Big Pharma’s Influence On “Patient Advocacy Groups” Shows Industry’s Control Of The Haystack Project, No Patient Left Behind, And The Community Oncology Alliance

Big Pharma's influence on patient advocacy groups

The BURDEN of Cancer Drug Prices On Patients. The RELIEF in the Inflation Reduction Act.